Loading
Arch Biopartners Inc. Stock: price and insider trades · Canada
CA·Mcap CA$56.4M
Arch Biopartners Inc.: what insiders have been doing
Arch Biopartners Inc. is a listed company. Its directors and officers file their transactions with SEDI. Over the twelve months to 18 October 2026, 127 filings were filed, from 1 insider.
On the market, 1 insider bought (93 purchases totalling €110k) while 1 insider sold (34 sales totalling €519k). Taken together, the sales exceed the purchases by €409k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. On the buying side, the filings list 1 senior executive among the declarants. Biggest ticket of the year: €106k, sold by Muruve, Richard Gabriel and made public on 28 July 2026 (0.29% of market cap).
The most recent open-market purchase was published on 5 October 2026, 12 days ago. Filings reach the SEDI feed a median of 5 days after the trade. Until a filing is published, the market cannot know about the trade.
Across the 2,121 companies tracked on its exchange, the median is 11 filings; at 127 filings, this issuer sits above that mark. The full history, which starts in 2026, counts 93 purchases against 34 sales.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Insider Decl.
127
Thresholds
n/a
Buy Volume
€109,820
93 ops. · all time
Sell Volume
€518,915
34 ops. · all time
Who traded when
BuySaleRichard Gabriel Muruve93 buys34 sales
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended September 2025 · cache
CA$0.83
Analyst consensus
Income statement
EBITDA-CA$1.3M
Net income-CA$1.6M0.0% margin
Valuation
Beta1.80
Balance sheet & cash
Market capCA$56.4M
Total debtCA$2.5M
Free Cash Flow-CA$1.6M
Profitability & ownership
ROA-954.3%
% insiders18.2%
% institutions0.0%
Last declaration on 5 October 2026
Declarations127 total
1,200 shares@ CA$0.840.0018% mcap0.1% of flowCommon SharesTSXSEDI:4786704
Canonical exit: 30 Dec 2026 (T+90)
1,000 shares@ CA$0.890.0016% mcap0.1% of flowCommon SharesTSXSEDI:4786699
7,000 shares@ CA$0.850.010% mcap0.6% of flowCommon SharesTSXSEDI:4786697
Canonical exit: 29 Dec 2026 (T+90)
117,000 shares@ CA$0.850.17% mcap9.8% of flowCommon SharesTSXSEDI:4786694
3,000 shares@ CA$0.840.0044% mcap0.2% of flowCommon SharesTSXSEDI:4786691
Canonical exit: 29 Dec 2026 (T+90)
500 shares@ CA$0.9350.0008% mcap0.1% of flowCommon SharesTSXSEDI:4777905
Canonical exit: 13 Dec 2026 (T+90)
500 shares@ CA$0.930.0008% mcap0.1% of flowCommon SharesTSXSEDI:4777904
1,000 shares@ CA$0.900.0015% mcap0.1% of flowCommon SharesTSXSEDI:4777903
Canonical exit: 13 Dec 2026 (T+90)
1,000 shares@ CA$0.930.0016% mcap0.1% of flowCommon SharesTSXSEDI:4777902
Canonical exit: 10 Dec 2026 (T+90)
1,500 shares@ CA$0.930.0024% mcap0.2% of flowCommon SharesTSXSEDI:4777901
Canonical exit: 10 Dec 2026 (T+90)
20,000 shares@ CA$0.940.032% mcap2.1% of flowCommon SharesTSXSEDI:4777900
1,100 shares@ CA$0.940.0018% mcap0.1% of flowCommon SharesTSXSEDI:4777898
Canonical exit: 10 Dec 2026 (T+90)
1,000 shares@ CA$0.940.0016% mcap0.1% of flowCommon SharesTSXSEDI:4777896
Canonical exit: 10 Dec 2026 (T+90)
5,000 shares@ CA$0.940.0081% mcap0.5% of flowCommon SharesTSXSEDI:4777046
500 shares@ CA$0.940.0008% mcap0.1% of flowCommon SharesTSXSEDI:4777045
Canonical exit: 8 Dec 2026 (T+90)
500 shares@ CA$0.930.0008% mcap0.1% of flowCommon SharesTSXSEDI:4777044
100 shares@ CA$1.000.0002% mcap0.0% of flowCommon SharesTSXSEDI:4777043
Canonical exit: 7 Dec 2026 (T+90)
200 shares@ CA$0.960.0003% mcap0.0% of flowCommon SharesTSXSEDI:4777042
Canonical exit: 7 Dec 2026 (T+90)
700 shares@ CA$0.950.0011% mcap0.1% of flowCommon SharesTSXSEDI:4777041
300 shares@ CA$1.040.0005% mcap0.0% of flowCommon SharesTSXSEDI:4774328
Canonical exit: 3 Dec 2026 (T+90)
1,200 shares@ CA$1.030.0021% mcap0.1% of flowCommon SharesTSXSEDI:4774319
Canonical exit: 30 Nov 2026 (T+90)
58,000 shares@ CA$1.020.10% mcap6.6% of flowCommon SharesTSXSEDI:4774320
1,100 shares@ CA$1.020.0019% mcap0.1% of flowCommon SharesTSXSEDI:4774321
Canonical exit: 30 Nov 2026 (T+90)
500 shares@ CA$1.030.0009% mcap0.1% of flowCommon SharesTSXSEDI:4774324
Canonical exit: 2 Dec 2026 (T+90)
200 shares@ CA$1.020.0004% mcap0.0% of flowCommon SharesTSXSEDI:4774325
Canonical exit: 2 Dec 2026 (T+90)
25 of 127 declarations
About Arch Biopartners Inc.
Arch Biopartners Inc. is a biotechnology company focused on developing innovative treatments for serious diseases. It is listed on the Toronto Stock Exchange under the symbol XTSE.
